The New Mutation, E46K, of α-Synuclein Causes Parkinson and Lewy Body Dementia

Annals of Neurology

Volumn 55, Issue 2, 2004, Pages 164-173

  Zarranz, Juan J ^a   Alegre, Javier ^b   Gómez Esteban, Juan C ^a   Lezcano, Elena ^a   Ros, Raquel ^b   Ampuero, Israel ^b   Vidal, Lídice ^b   Hoenicka, Janet ^b   Rodriguez, Olga ^a   Atarés, Begoña ^c   Llorens, Verónica ^d   Gomez Tortosa, Estrella ^b,e   Del Ser, Teodoro ^f   Muñoz, David G ^b   De Yebenes, Justo G ^b,e  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Banco Tejidos Invest Neurologicas   (Spain)

^c HOSPITAL TXAGORRITXU   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^f HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; GLUTAMIC ACID; LYSINE; UBIQUITIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; AUTOPSY; AUTOSOMAL DOMINANT DISORDER; BRAIN ATROPHY; BRAIN CORTEX; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; E46K GENE; FAMILIAL DISEASE; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PARKINSONISM; PEDIGREE; PRIORITY JOURNAL; PROTEIN FUNCTION; SPAIN; SUBSTANTIA NIGRA; VISUAL HALLUCINATION;

AGED; ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; BASE SEQUENCE; BRAIN; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; LEWY BODY DISEASE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NERVE DEGENERATION; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PEDIGREE; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SYNUCLEINS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 10744230149     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10795     Document Type: Article

References (51)

1. Elbaz A, Grigoletto F, Baldereschi M, et al. Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group. Neurology 1999;52:1876-1882.
2. Wszolek ZK, Uitti RJ, Markopoulou K. Familial Parkinson's disease and related conditions. Clinical genetics. Adv Neurol 2001;86:33-43.
3. Payami H, Zareparsi S, James, Nutt J. Familial aggregation of Parkinson's disease: a comparative study of early-onset disease. Arch Neurol 2002;59:848-850.
4. Golbe LI, Di Iorio G, Bonavita V, et al. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 1990;27:276-282.
5. Polymeropoulos MH, Higgins JJ, Golbe LE, et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996;274:1197-1198.
6. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alfa-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
7. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-452.
8. Kruger R, Khun W, Muller T, et al. Ala30-to-pro mutation in the gene encoding alfa-synuclein in Parkinson's disease. Nat Genet 1998;18:106-108.
9. Gasser T, Müller-Mysok B, Wszolek ZK, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998;18:262-265.
10. Farrer M, Gwinn-Hardy K, Muenter M, et al. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet 1999;8:81-85.
11. Funayama M, Hasegawa K, Kowa H, et al. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 2002;51:296-301.
12. Le W, Xu P, Jankovic J, et al. Mutations in NR4A2 associated with familial Parkinson's disease. Nat Gent 2003;33:85-89.
13. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-608.
14. Valente EM, Bentivoglio AR, Dixon DH, et al. Localization of a novel locus for autosomal recessive early-onset parkinsonism, park6, on human chromosome 1p35-p36. Am J Hum Genet 2001;68:895-900.
15. van Duijn CM, Dekker MC, Bonifati V, et al. Park7, a novel locus for autosomal recessive early-onset parkinsonism on chromosome 1p36. Am J Hum Genet 2001;69:629-634.
16. Bonifati V, Rizzu P, van Baren MJ, et al. Mutation in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003;299:256-259.
17. Golbe LE, Di Iorio G, Sanges G, et al. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 1996;40:767-775.
18. Lynch T, Sano M, Marder KS, et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology 1994;44:1878-1884.
19. Wilhelmsen KC, Lynch T, Pavlou E, et al. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 1994;55:1159-1165.
20. Spillantini MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998;95:7737-7741.
21. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia and FTDP-17. Nature 1998;393:702-705.
22. Kosaka K, Oyanagi S, Matsushita M, Hori A. Presenile dementia with Alzheimer-, Pick- and Lewy-body changes. Acta Neuropathol 1976;36:221-233.
23. Kosaka K, Iseki E. Dementia with Lewy bodies. Curr Opin Neurol 1996;9:271-275.
24. Iseki E, Marui W, Kosaka K, Ueda K. Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neurosci Lett 1999;265:9-12.
25. Mattila PM, Roytta M, Torikka H, et al. Cortical Lewy bodies and Alzheimer-type change in patients with Parkinson's disease. Acta Neuropathol 1998;95:576-582.
26. Samuel W, Galasko D, Masliah E, et al. Neocortical Lewy body count correlate with dementia in the Lewy body variant of Alzheimer disease. J Neuropathol Exp Neurol 1996;55:44-52.
27. Gomez-Tortosa E, Newell K, Irizarry MC, et al. Clinical and quantitative pathological correlates of dementia with Lewy bodies. Neurology 1999;53:1284-1291.
28. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996;49:1113-1124.
29. McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop. Neurology 1999;53:902-905.
30. Harding AJ, Halliday GM. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 2001;102:355-363.
31. Golbe LE, Lazzarini AM, Schwarz KO, et al. Autosomal dominant parkinsonism with benign course and typical Lewy-body pathology. Neurology 1993;43:2222-2227.
32. Denson MA, Wszolek ZK, Pfeiffer RF, et al. Familial dementia, dementia and Lewy body disease: study of family G. Ann Neurol 1997;42:638-643.
33. Ishikawa A, Takahashi H, Tanaka H, et al. Clinical features of familial diffuse Lewy body disease. Eur Neurol 1997;38(suppl 1):34-38.
34. Farrer M, Gwinn-Hardy K, Hutton M, Hardy J. The genetics of disorders with synuclein pathology and parkinsonism. Hum Mol Genet 1998;7:751-753.
35. Ohara K, Takauchi S, Kokai M, et al. Familial dementia with Lewy bodies (DLB). Clin Neuropathol 1999;18:232-239.
36. Brett FM, Henson C, Staunton H. Familial diffuse Lewy body disease, eye movement abnormalities and distribution of pathology. Arch Neurol 2002;59:464-467.
37. Tsuang DW, Dalan AM, Eugenio CJ, et al. Familial dementia with Lewy bodies. A clinical and neuropathological study of 2 families. Arch Neurol 2002;59:1622-1630.
38. Galvin JE, Lee SL, Perry A, et al. Familial dementia with Lewy bodies: clinicopathologic analysis of two kindreds. Neurology 2002;59:1079-1082.
39. Walker Z, Costa DC, Walker RWH, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry 2002;73:134-140.
40. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiat 1992;55:181-184.
41. Duda JE, Giasson BI, Mabon ME, et al. Concurrence of α-synuclein and tau pathology in the Contursi kindred. Acta Neuropathol 2002;104:7-11.
42. Galvin JE, Lee VM-Y, Trojanowski JQ. Synucleinopathies. Clinical and pathological implications. Arch Neurol 2001;58:186-190.
43. Rockenstein E, Hansen LA, Mallory M, et al. Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease. Brain Res 2001;914:48-56.
44. Masliah E, Rockenstein E, Veinbergs I, et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implication for neurodegenerative disorders. Science 2000;287:1265-1269.
45. Abeliovich A, Schmitz Y, Fariñas I, et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000;25:239-252.
46. Lotharius J, Barg S, Wiekop P, et al. Effect of alpha-synuclein on dopamine homeostasis in a new human mesencephalic line. J Biol Chem 2002;277:38884-38894.
47. Gwinn-Hardy K, Mehta ND, Farrer M, et al. Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol 2000;98:663-672.
48. Sanchez M, Gonzalo I, Avila J, De Yé benes JG. Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin mutation. J Alzheimers Dis 2002;4:399-404.
49. Paxinou E, Chen Q, Weisse M, et al. Induction of alpha-synuclein aggregation by intracellular nitrative insult. J Neurosci 2001;21:8053-8061.
50. Lee HJ, Shin SY, Choi C, et al. Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. J Biol Chem 2002;277:5411-5417.
51. Saito Y, Kawashima A, Ruberu NN, et al. Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 2003;62:644-654.